Js. Berner et al., SEQUELAE AFTER ESOPHAGEAL VARICEAL LIGATION AND SCLEROTHERAPY - A PROSPECTIVE RANDOMIZED STUDY, The American journal of gastroenterology, 89(6), 1994, pp. 852-858
Objectives: Esophageal variceal ligation is a new approach to the trea
tment of esophageal varices that does not result in transmural tissue
injury and inflammation, and therefore might produce fewer sequelae an
d symptoms than sclerotherapy. We conducted a prospective, randomized
comparison of sclerotherapy with ligation to study the relative short-
term risks of these two procedures with respect to bacteremia, pulmona
ry and coagulation function, esophageal motility, and gastroesophageal
reflux. Methods: Patients with previously documented high grade esoph
ageal varices were randomized to receive sclerotherapy or ligation. Bl
ood was drawn for culture and coagulation profiles, and patients under
went pulmonary function tests, esophageal manometry, and intraesophage
al pH monitoring before and after treatment. Results: Six patients wit
h Childs class B cirrhosis and one patient with presinusoidal portal h
ypertension underwent 20 courses of therapy. Neither sclerotherapy nor
ligation produced significant clinical changes in pulmonary or coagul
ation parameters, or bacteremia requiring treatment. The majority of l
igation treatments were without worsening of motility or reflux scores
, and none were associated with symptoms. Sclerotherapy was followed b
y significantly greater esophageal dysmotility and worsening reflux pa
tterns. Conclusions: Patient acceptance of ligation was much greater t
han that for sclerotherapy. Our data define the advantages of ligation
over sclerotherapy.